Product Images Sumatriptan And Naproxen Sodium

This is a description of a medication called Sumatriptan and Naproxen Sodium Tablets, containing 85mg/500mg of the respective drugs per tablet. The medication is manufactured by Imovida Pharmaceuticals Corporation, and each tablet must be ingested whole and dispensed in a tightly-sealed, child-resistant container. The packaging includes a manufacturer address in India.*

This text is a medication guide for Sumatriptan and Naproxen Sodium Tablets. It includes important information about the risks of taking the medication, such as an increased chance of heart attack or stroke, and the potential for ulcers and bleeding in the stomach and intestines. It also lists who should not take this medication, such as those with heart problems or high blood pressure, and provides instructions on how to take the medication. Overall, this text provides important information for anyone considering taking Sumatriptan and Naproxen Sodium Tablets.*

This is a medication guide for Sumatriptan and Naproxen tablets. The guide provides information on how to take the tablets, what to avoid while taking the medication, the possible side effects and ingredients in the medication. It also provides general information on the safe and effective use of Sumatriptan and Naproxen tablets. Instructions are provided on how to store the medication, and the guide has been approved by the US Food and Drug Administration.*

The text describes a figure that shows the estimated probability of adults taking a rescue medication over 24 hours following the first dose. The figure compares the percentages of patients taking a rescue medication for placebo, naproxen, sumatriptan, and sumatriptan combined with naproxen sodium tablets. The data is shown for specific hours postdose.*

Not available.*